Embrace the Opportunities in a Changing FDA Advisory Committee Landscape

Over the past 4 years, we’ve seen seismic shifts in the conduct of FDA Advisory Committee meetings (AdComs). In our white paper, titled Embrace the Opportunities in a Changing FDA Advisory Committee Landscape, published on the DIA Global Forum, we explore how those changes are creating new challenges and opportunities for sponsors.

8 Minutes